-
Autor
Amato, Maria Pia 4 Butzkueven, Helmut 4 Ozakbas, Serkan 4 Patti, Francesco 4 Alroughani, Raed 3 Boz, Cavit 3 Eichau, Sara 3 Gerlach, Oliver 3 Grammond, Pierre 3 Grand'Maison, Francois 3 Horakova, Dana 3 Kalincik, Tomas 3 Khoury, Samia J 3 Laureys, Guy 3 Lechner-Scott, Jeannette 3 Shaygannejad, Vahid 3 Ampapa, Radek 2 Beyersdorf, Friedhelm 2 Buzzard, Katherine 2 Casey, Romain 2
- Organizace
-
Pracoviště
The Alfred Hospital Melbourne Australia 7 Dokuz Eylul University Konak Izmir Tu... 4 Department of Medical and Surgical Sc... 3 Hospital Universitario Virgen Macaren... 3 KTU Medical Faculty Farabi Hospital T... 3 Monash University Melbourne Australia 3 Neuro Rive Sud Quebec Canada 3 American University of Beirut Medical... 2 Amiri Hospital Sharq Kuwait 2 Austin Health Melbourne Australia 2 CHU Clermont Ferrand Department of Ne... 2 CSSS Saint Jérôme Saint Jerome Canada 2 Central Clinical School Monash Univer... 2 Department of Neurology The Alfred Ho... 2 German Heart Center Berlin Germany 2 Groene Hart Ziekenhuis Gouda Netherlands 2 Hannover Medical School Hannover Germany 2 Heart Center Leipzig Leipzig Germany 2 Institute for Clinical and Experiment... 2 Isfahan University of Medical Science... 2
- Formát
- Publikační typ
- Check Tag
-
Kategorie
A : Anatomie 3 B : Organismy 6 C : Nemoci 6 D : Chemikálie a léčiva 2 E : Analytické, diagnostic... 5 G : Jevy a procesy 3 H : Obory a povolání 1 I : Antropologie, vzdělává... 1 K : Humanitní vědy 1 L : Informační vědy 1 M : Lidé 4 N : Zdravotní péče 5 V : Publikační charakteris... 7 Z : Geografická místa 2
- Zeměpisné označení
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
-
Autor
Amato, Maria Pia 4 Butzkueven, Helmut 4 Ozakbas, Serkan 4 Patti, Francesco 4 Alroughani, Raed 3 Boz, Cavit 3 Eichau, Sara 3 Gerlach, Oliver 3 Grammond, Pierre 3 Grand'Maison, Francois 3 Horakova, Dana 3 Kalincik, Tomas 3 Khoury, Samia J 3 Laureys, Guy 3 Lechner-Scott, Jeannette 3 Shaygannejad, Vahid 3 Ampapa, Radek 2 Beyersdorf, Friedhelm 2 Buzzard, Katherine 2 Casey, Romain 2
- Organizace
-
Pracoviště
The Alfred Hospital Melbourne Australia 7 Dokuz Eylul University Konak Izmir Tu... 4 Department of Medical and Surgical Sc... 3 Hospital Universitario Virgen Macaren... 3 KTU Medical Faculty Farabi Hospital T... 3 Monash University Melbourne Australia 3 Neuro Rive Sud Quebec Canada 3 American University of Beirut Medical... 2 Amiri Hospital Sharq Kuwait 2 Austin Health Melbourne Australia 2 CHU Clermont Ferrand Department of Ne... 2 CSSS Saint Jérôme Saint Jerome Canada 2 Central Clinical School Monash Univer... 2 Department of Neurology The Alfred Ho... 2 German Heart Center Berlin Germany 2 Groene Hart Ziekenhuis Gouda Netherlands 2 Hannover Medical School Hannover Germany 2 Heart Center Leipzig Leipzig Germany 2 Institute for Clinical and Experiment... 2 Isfahan University of Medical Science... 2
- Formát
- Publikační typ
- Check Tag
-
Kategorie
A : Anatomie 3 B : Organismy 6 C : Nemoci 6 D : Chemikálie a léčiva 2 E : Analytické, diagnostic... 5 G : Jevy a procesy 3 H : Obory a povolání 1 I : Antropologie, vzdělává... 1 K : Humanitní vědy 1 L : Informační vědy 1 M : Lidé 4 N : Zdravotní péče 5 V : Publikační charakteris... 7 Z : Geografická místa 2
- Zeměpisné označení
- Jazyk
- Země
- Časopis/zdroj
- Dostupnost
- Vlastník
It is unknown whether the currently known risk factors of multiple sclerosis reflect the etiology of progressive-onset multiple sclerosis (POMS) as observational studies rarely included analysis by type of onset. We designed a case-control study to examine associations between environmental factors and POMS and compared effect sizes to relapse-onset MS (ROMS), which will offer insights into the etiology of POMS and potentially contribute to prevention and intervention practice. This study utilizes data from the Primary Progressive Multiple Sclerosis (PPMS) Study and the Australian Multi-center Study of Environment and Immune Function (the AusImmune Study). This report outlines the conduct of the PPMS Study, whether the POMS sample is representative, and the planned analysis methods. The study includes 155 POMS, 204 ROMS, and 558 controls. The distributions of the POMS were largely similar to Australian POMS patients in the MSBase Study, with 54.8% female, 85.8% POMS born before 1970, mean age of onset of 41.44 ± 8.38 years old, and 67.1% living between 28.9 and 39.4° S. The POMS were representative of the Australian POMS population. There are some differences between POMS and ROMS/controls (mean age at interview: POMS 55 years vs. controls 40 years; sex: POMS 53% female vs. controls 78% female; location of residence: 14.3% of POMS at a latitude ≤ 28.9°S vs. 32.8% in controls), which will be taken into account in the analysis. We discuss the methodological issues considered in the study design, including prevalence-incidence bias, cohort effects, interview bias and recall bias, and present strategies to account for it. Associations between exposures of interest and POMS/ROMS will be presented in subsequent publications.
- MeSH
- chronicko-progresivní roztroušená skleróza * epidemiologie etiologie MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- multicentrické studie jako téma MeSH
- recidiva MeSH
- rizikové faktory MeSH
- roztroušená skleróza * epidemiologie etiologie MeSH
- studie případů a kontrol MeSH
- věk při počátku nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Austrálie MeSH
- Spelman, Tim
- Eichau, Sara
- Alroughani, Raed
- Ozakbas, Serkan
- Khoury, Samia J
- Patti, Francesco
- Kubala Havrdova, Eva
- Boz, Cavit
- Terzi, Murat
-
Kuhle, Jens
Autor Kuhle, Jens Department of Neurology, University Hospital and University of Basel, Basel, Switzerland Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland
Free Medical Journals od 2015
PubMed Central od 2015
Europe PubMed Central od 2015
ProQuest Central od 2015-01-01
Open Access Digital Library od 2015-04-01
Health & Medicine (ProQuest) od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources od 2015
PubMed
38800132
DOI
10.1177/20552173241247182
Knihovny.cz E-zdroje
BACKGROUND: The use of non-specific immunosuppressants (NSIS) to treat multiple sclerosis (MS) remains prevalent in certain geographies despite safety concerns, likely due to resource limitations. OBJECTIVE: To use MSBase registry data to compare real-world outcomes in adults with relapsing-remitting MS (RRMS) treated with dimethyl fumarate (DMF) or NSIS (azathioprine, cyclosporine, cyclophosphamide, methotrexate, mitoxantrone or mycophenolate mofetil) between January 1, 2014 and April 1, 2022. METHODS: Treatment outcomes were compared using inverse probability of treatment weighting (IPTW) Cox regression. Outcomes were annualized relapse rates (ARRs), time to discontinuation, time to first relapse (TTFR) and time to 24-week confirmed disability progression (CDP) or 24-week confirmed disability improvement (CDI; in patients with baseline Expanded Disability Status Scale [EDSS] score ≥2). RESULTS: After IPTW, ARR was similar for DMF (0.13) and NSIS (0.16; p = 0.29). There was no difference in TTFR between cohorts (hazard ratio [HR]: 0.98; p = 0.84). The DMF cohort experienced longer times to discontinuation (HR: 0.75; p = 0.001) and CDP (HR: 0.53; p = 0.001), and shorter time to CDI (HR: 1.99; p < 0.008), versus the NSIS cohort. CONCLUSION: This analysis supports the use of DMF to treat patients with relapsing forms of MS, and may have implications for MS practices in countries where NSIS are commonly used to treat RRMS.
- Publikační typ
- časopisecké články MeSH
-
Roos, Izanne
Autor Roos, Izanne ORCID From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Malpas, Charles
Autor Malpas, Charles From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Leray, Emmanuelle
Autor Leray, Emmanuelle From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Casey, Romain
Autor Casey, Romain ORCID From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Horakova, Dana
Autor Horakova, Dana From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Havrdova, Eva Kubala
Autor Havrdova, Eva Kubala From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Debouverie, Marc
Autor Debouverie, Marc From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Patti, Francesco
Autor Patti, Francesco From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
De Seze, Jerome
Autor De Seze, Jerome From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
-
Izquierdo, Guillermo
Autor Izquierdo, Guillermo From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne, Australia Melbourne MS Centre (I.R., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes, University (E.L.), EHESP, REPERES EA 7449, France Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 ([Centre d'Investigation Clinique de Rennes]), France Université de Lyon (R.C.), Université Claude Bernard Lyon 1, France Hospices Civils de Lyon (R.C.), Service de Neurologie, Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Bron, France Observatoire Français de La Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, France Eugène Devic EDMUS Foundation Against Multiple Sclerosis (R.C.), State-approved Foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.K.H.), First Faculty of Medicine, Charles University in Prague and General University Hospital, Czech Republic Nancy University Hospital (M.D.), Department of Neurology, Nancy, France Université de Lorraine (M.D.), APEMAC, Nancy, France Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia, Catania, Italy Multiple Sclerosis Center (F.P.), University of Catania, Italy CHU de Strasbourg (J.D.S.), Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, Strasbourg, France Hospital Universitario Virgen Macarena (G.I., S.E.), Sevilla, Spain CHU Pontchaillou (G.E.), CIC1414 INSERM, Rennes, France CHUM MS Center and Universite de Montreal (A.P., M.G.), Canada Dokuz Eylul University (S.O.), Konak/Izmir, Turkey CISSS Chaudière-Appalache (P.G.), Levis, Canada CHU Lille (H.Z.), CRCSEP Lille, Univ Lille, U1172, France CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, France Département de Neurologie (E.M.), Hôpital Pitié-Salpêtrière, APHP, Paris CHU de Dijon (T.M.), Department of Neurology, EA4184, France Department NEUROFARBA (M.P.A.), University of Florence, Italy CHU de Montpellier (P.L.), MS Unit, France University of Montpellier (MUSE) (P.L.), France Division of Neurology (Raed Alroughani), Department of Medicine, Amiri Hospital, Sharq, Kuwait Department of Neurology (K.B., O.S.), Box Hill Hospital, Melbourne, Australia Monash University (K.B., O.S.), Melbourne, Australia Melbourne MS Centre (K.B.), Royal Melbourne Hospital, Australia The Alfred Hospital (O.S.), Melbourne, Australia Medical Faculty (M.T.), 19 Mayis University, Samsun, Turkey CHU de Nantes (D.A.L.), Service de Neurologie & CIC015 INSERM, France CRTI-Inserm U1064 (D.A.L.), Nantes, France CHU de Besançon (E.B.), Service de Neurologie 25 030 Besançon, France Neuro Rive-Sud (F.G.M.), Quebec, Canada Neurology (C.L.-F.), UR2CA, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France UOC Neurologia (E.C.), Azienda Sanitaria Unica Regionale Marche-AV3, Macerata, Italy KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey School of Medicine and Public Health (J.L.-S.), University Newcastle, Australia Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle, Australia CHU Clermont-Ferrand (Pierre Clavelou), Department of Neurology Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, France Sorbonne Universités (B.S.), UPMC Paris 06, Brain and Spine Institute, ICM, Hôpital de La Pitié Salpêtrière, Inserm UMR S 1127, CNRS UMR 7225, and Department of Neurology, AP-HP, Saint-Antoine Hospital, Paris, France CSSS Saint-Jérôme (Julie Prevost), Saint-Jerome, Canada Neurologic Clinic and Policlinic (L.K.), Departments of Medicine and Clinical Research, University Hospital and University of Basel, Switzerland Aix Marseille Univ (Jean Pelletier), APHM, Hôpital de La Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Isfahan University of Medical Sciences (V.S.), Iran Nehme and Therese Tohme Multiple Sclerosis Center (B.I.Y., S.J.K.), American University of Beirut Medical Center, Beirut, Lebanon Department of Neurology (Oliver Gerlach), Zuyderland Medical Center, Sittard-Geleen, Netherlands Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino (D.L.A.S.), Italy Cliniques Universitaires Saint-Luc (V.V.P.), Université Catholique de Louvain, Brussels, Belgium Fondation Rotschild (Olivier Gout), Department of Neurology, Paris, France Haydarpasa Numune Training and Research Hospital (R.T.), Istanbul, Turkey Hôpital de Poissy (O.H.), Department of Neurology, France Department of Neurology (E.T.), Nimes University Hospital, France Institut de Génomique Fonctionnelle (E.T.), UMR5203, INSERM 1191, Univ. Montpellier, France University of Queensland (P.A.M.), Brisbane, Australia Royal Brisbane and Women's Hospital (P.A.M.), Australia Bakirkoy Education and Research Hospital for Psychiatric and Neurological Diseases (A.S.), Istanbul, Turkey CHU de Rouen (B.B.), Department of Neurology, France Flinders University (M.S.), Adelaide, Australia Instituto de Investigación Sanitaria Biodonostia (T.C.-T.), Hospital Universitario Donostia, San Sebastián, Spain CHU de Reims (S.B.), Department of Neurology, France Nemocnice Jihlava (Radek Ampapa), Czech Republic Monash Medical Centre (E.G.B.), Melbourne, Australia APHP (A.W.), Hôpital Henri Mondor, Department of Neurology, Créteil, France Austin Health (R.A.M.), Melbourne, Australia University Hospital Reina Sofia (E.A.-M.), Cordoba, Spain CHU de La Martinique (Philippe Cabre), Department of Neurology, Fort-de-France, France Hôpital Sud Francilien (N.H.B.), Department of Neurology, Corbeil Essonnes, France Department of Neurology (A.V.W., H.B.), The Alfred Hospital, Melbourne, Australia Central Clinical School (A.V.W., H.B.), Monash University, Melbourne, Australia Department of Neurology (G.L., L.V.H.), University Hospital Ghent, Belgium Hospital Germans Trias I Pujol (C.M.R.-T.), Badalona, Spain CHU La Milétrie (N.M.), Hôpital Jean Bernard, Department of Neurology, Poitiers, France Liverpool Hospital (S.H.), Sydney, Australia Hospital de Galdakao-Usansolo (J.L.S.-M.), Spain Brain and Mind Centre (M.H.B.), Sydney, Australia CHU Bicêtre (C.L.), Department of Neurology, F-94275 Le Kremlin Bicêtre, France Westmead Hospital (Steve Vucic), Sydney, Australia Department of Neurology (Y.S., R.G.), Razi Hospital, Manouba, Tunisia Department of Neurology (T.C.), Faculty of Medicine, University of Debrecen, Hungary Hospital Universitari MútuaTerrassa (J.S.), Barcelona, Spain Groene Hart Ziekenhuis (K.G.), Gouda, Netherlands Sultan Qaboos University Hospital (A.A.-A.), Al-Khodh, Oman Universidade Metropolitana de Santos (Y.D.F.), Santos, Brazil Service de Neurologie (Sandra Vukusic), Sclérose en Plaques, Pathologies de La Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre des Neurosciences de Lyon (Sandra Vukusic), Observatoire Français de La Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, France and Université Claude Bernard Lyon 1 (Sandra Vukusic), Faculté de Médecine Lyon Est, France
BACKGROUND AND OBJECTIVES: To evaluate the rate of return of disease activity after cessation of multiple sclerosis (MS) disease-modifying therapy. METHODS: This was a retrospective cohort study from 2 large observational MS registries: MSBase and OFSEP. Patients with relapsing-remitting MS who had ceased a disease-modifying therapy and were followed up for the subsequent 12 months were included in the analysis. The primary study outcome was annualized relapse rate in the 12 months after disease-modifying therapy discontinuation stratified by patients who did, and did not, commence a subsequent therapy. The secondary endpoint was the predictors of first relapse and disability accumulation after treatment discontinuation. RESULTS: A total of 14,213 patients, with 18,029 eligible treatment discontinuation epochs, were identified for 7 therapies. Annualized rates of relapse (ARRs) started to increase 2 months after natalizumab cessation (month 2-4 ARR 0.47, 95% CI 0.43-0.51). Commencement of a subsequent therapy within 2-4 months reduced the magnitude of disease reactivation (mean ARR difference: 0.15, 0.08-0.22). After discontinuation of fingolimod, rates of relapse increased overall (month 1-2 ARR: 0.80, 0.70-0.89) and stabilized faster in patients who started a new therapy within 1-2 months (mean ARR difference: 0.14, -0.01 to 0.29). The magnitude of disease reactivation for other therapies was low but reduced further by commencement of another treatment 1-10 months after treatment discontinuation. Predictors of relapse were a higher relapse rate in the year before cessation, female sex, younger age, and higher EDSS score. Commencement of a subsequent therapy reduced both the risk of relapse (HR 0.76, 95% CI 0.72-0.81) and disability accumulation (0.73, 0.65-0.80). DISCUSSION: The rate of disease reactivation after treatment cessation differs among MS treatments, with the peaks of relapse activity ranging from 1 to 10 months in untreated cohorts that discontinued different therapies. These results suggest that untreated intervals should be minimized after stopping antitrafficking therapies (natalizumab and fingolimod). CLASSIFICATION OF EVIDENCE: This study provides Class III that disease reactivation occurs within months of discontinuation of MS disease-modifying therapies. The risk of disease activity is reduced by commencement of a subsequent therapy.
- MeSH
- fingolimod hydrochlorid terapeutické užití MeSH
- imunosupresiva škodlivé účinky MeSH
- lidé MeSH
- natalizumab terapeutické užití MeSH
- recidiva MeSH
- relabující-remitující roztroušená skleróza * farmakoterapie epidemiologie MeSH
- retrospektivní studie MeSH
- roztroušená skleróza * chemicky indukované MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
- práce podpořená grantem MeSH
-
Roos, Izanne
Autor Roos, Izanne From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Leray, Emmanuelle
Autor Leray, Emmanuelle From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Casey, Romain
Autor Casey, Romain From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Horakova, Dana
Autor Horakova, Dana From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Havrdova, Eva
Autor Havrdova, Eva From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Izquierdo, Guillermo
Autor Izquierdo, Guillermo From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Madueño, Sara Eichau
Autor Madueño, Sara Eichau From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Patti, Francesco
Autor Patti, Francesco From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Edan, Gilles
Autor Edan, Gilles From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
-
Debouverie, Marc
Autor Debouverie, Marc From the CORe (I.R., C.M., T.K.), Department of Medicine, University of Melbourne Melbourne MS Centre (I.R., K.B., C.M., T.K.), Department of Neurology, Royal Melbourne Hospital, Australia Rennes University (E.L.), EHESP, REPERES EA 7449 Univ Rennes (E.L.), CHU Rennes, Inserm, CIC 1414 (Centre d'Investigation Clinique de Rennes) Université de Lyon (R.C.), Université Claude Bernard Lyon 1 Hospices Civils de Lyon (R.C.), Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron Observatoire Français de la Sclérose en Plaques (R.C.), Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292 EUGENE DEVIC EDMUS Foundation Against Multiple Sclerosis (R.C.), state-approved foundation, Bron, France Department of Neurology and Center of Clinical Neuroscience (D.H., E.H.), First Faculty of Medicine, Charles University General University Hospital (D.H., E.H.), Prague, Czech Republic Hospital Universitario Virgen Macarena (G.I., S.E.M.), Sevilla, Spain Department of Medical and Surgical Sciences and Advanced Technologies (F.P.), GF Ingrassia Multiple Sclerosis Center (F.P.), University of Catania, Italy Centre hospitalier universitaire de Rennes (G.E.), Hôpital Pontchaillou, Service de neurologie, CIC1414 INSERM Nancy University Hospital (M.D.), Department of Neurology Université de Lorraine (M.D.), APEMAC, Nancy, France Aix Marseille Univ (J.P.), APHM, Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, France Dokuz Eylul University (S.O.), Konak/Izmir, Turkey Department of Neurosciences, Psychology, Drugs and Child Health Area (NEUROFARBA) (M.P.A.), Section Neurosciences, University of Florence, Italy CHU Clermont-Ferrand (P.C.), Department of Neurology Université Clermont Auvergne (P.C.), Inserm, Neuro-Dol, Clermont-Ferrand, France CISSS Chaudière-Appalache (P.G.), Lévis, Canada KTU Medical Faculty Farabi Hospital (C.B.), Trabzon, Turkey Department of Neurology (K.B., O.S., H.B.), Box Hill Hospital, Monash University The Alfred Hospital (O.S.), Melbourne, Australia CHU de Toulouse (J.C.), Hôpital Pierre-Paul Riquet, Department of Neurology, CRC-SEP, Toulouse Cedex 9, France Department of Neurology (O.G.), Zuyderland Medical Center, Sittard-Geleen, the Netherlands Neuro Rive-Sud (F.G.), Quebec, Canada School of Medicine and Public Health (J.L.-S.), University Newcastle Department of Neurology (J.L.-S.), John Hunter Hospital, Hunter New England Health, Newcastle Central Clinical School (H.B.), Monash University Department of Neurology (H.B.), The Alfred Hospital, Melbourne, Australia Service de neurologie (S.V.), sclérose en plaques, pathologies de la myéline et neuro-inflammation Hôpital Neurologique Pierre Wertheimer (S.V.), Hospices Civils de Lyon, Lyon/Bron France Centre des Neurosciences de Lyon (S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292 and Université Claude Bernard Lyon 1 (S.V.), Faculté de médecine Lyon Est, France
OBJECTIVE: To compare the clinical effectiveness of high- and low-efficacy treatments in patients with recently active and inactive secondary progressive multiple sclerosis (SPMS) after accounting for therapeutic lag. METHODS: Patients treated with high-efficacy (natalizumab, alemtuzumab, mitoxantrone, ocrelizumab, rituximab, cladribine, fingolimod) or low-efficacy (interferon beta, glatiramer acetate, teriflunomide) therapies after SPMS onset were selected from MSBase and Observatoire Français de la Sclérose en Plaques (OFSEP), 2 large observational cohorts. Therapeutic lag was estimated for each patient from their demographic and clinical characteristics. Propensity score was used to match patients treated with high- and low-efficacy therapies. Outcomes after the period of therapeutic lag was disregarded were compared in paired, pairwise-censored analyses. RESULTS: One thousand patients were included in the primary analysis. Patients with active SPMS treated with high-efficacy therapy experienced less frequent relapses than those on low-efficacy therapy (hazard ratio [HR] 0.7, p = 0.006). In patients with inactive SPMS, there was no evidence for a difference in relapse frequency between groups (HR 0.8, p = 0.39). No evidence for a difference in the risk of disability progression was observed. CONCLUSION: In treated patients with SPMS, high-efficacy therapy is superior to low-efficacy therapy in reducing relapses in patients with active but not those with inactive SPMS. However, more potent therapies do not offer an advantage in reducing disability progression in this patient group. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that high-efficacy therapy is superior to low-efficacy therapy in reducing relapses in patients with active SPMS, although we did not find a difference in disability progression between patients treated with high- and low-efficacy therapy.
- MeSH
- chronicko-progresivní roztroušená skleróza * farmakoterapie MeSH
- glatiramer acetát terapeutické užití MeSH
- lidé MeSH
- natalizumab MeSH
- relabující-remitující roztroušená skleróza * MeSH
- roztroušená skleróza * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- komentáře MeSH
- práce podpořená grantem MeSH
Wiley Free Content od 1999 do Před 1 rokem
PubMed
30052304
DOI
10.1002/ejhf.1284
Knihovny.cz E-zdroje
AIM: This study aimed to assess safety and outcomes of patients, 2 years after implantation with the HeartMate 3 Left Ventricular Assist System. METHODS AND RESULTS: This study included 50 adults with New York Heart Association (NYHA) class IIIB or IV symptoms or American College of Cardiology/American Heart Association stage D heart failure with an ejection fraction ≤25% and a cardiac index ≤2.2 L/min/m2 without inotropes, or inotrope-dependent with optimal medical management, or listed for heart transplant. The median duration of left ventricular assist device support was 694 days (range: 19-833 days). At baseline, cardiac index was 1.8 ±0.5 L/min/m2 , 58% of patients were receiving inotropes, and 92% were INTERMACS profiles 2-4. At 2 years, Kaplan-Meier survival was 74 ±6%, 5 (10%) patients were transplanted, and 32 patients (64%) remain with support. Adverse event rates include bleeding requiring surgery (16%), gastrointestinal bleeding (20%), driveline infection (24%), ischaemic stroke (16%), haemorrhagic stroke (8%), right heart failure (14%), and outflow graft thrombosis (2%). Notably, no haemolysis, pump thrombosis, or pump malfunction events occurred. At 2 years, 47% of patients remained in NYHA class I and 41% in NYHA class II (P <0.0001). From baseline to 2 years, the mean six-minute walk distance increased from 239 m to 347 m (P <0.0001), and the mean EQ-5D quality of life score improved from 48.2 to 70.6 (P < 0.0001). CONCLUSIONS: Two years post-HeartMate 3 implantation, results show expected and acceptable survival, enhanced haemocompatibility, improved patient functional status and quality of life. This corroborates the success of HeartMate 3 since its first-in-man implantation case in Germany. ClinicalTrials.gov: NCT02170363.
- MeSH
- časové faktory MeSH
- design vybavení MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití trendy MeSH
- následné studie MeSH
- podpůrné srdeční systémy * MeSH
- prospektivní studie MeSH
- srdeční komory patofyziologie MeSH
- srdeční selhání mortalita patofyziologie terapie MeSH
- tepový objem fyziologie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Austrálie MeSH
- Evropa MeSH
- Kanada MeSH
- Kazachstán MeSH
- Spojené státy americké MeSH
PubMed
30079597
DOI
10.1002/ccd.27714
Knihovny.cz E-zdroje
BACKGROUND: Transcatheter Aortic Valve Implantation (TAVI) is commonly used to deploy new bioprosthetic valves inside degenerated surgically implanted aortic valves in high risk patients. The three scoring systems used to assess risk of postprocedural mortality are: Logistic EuroSCORE (LES), EuroSCORE II (ES II), and Society of Thoracic Surgeons (STS). OBJECTIVE: The purpose of this study is to analyze the accuracy of LES, ES II, and STS in estimating all-cause mortality after transcatheter aortic valve-in-valve (ViV) implantations, which was not assessed before. METHODS: Using the Valve-in-Valve International Data (VIVID) registry, a total of 1,550 patients from 110 centers were included. The study compared the observed 30-day overall mortality vs. the respective predicted mortalities calculated by risk scores. The accuracy of prediction models was assessed based on calibration and discrimination. RESULTS: Observed mortality at 30 days was 5.3%, while average expected mortalities by LES, ES II and STS were 29.49 (± 17.2), 14.59 (± 8.6), and 9.61 (± 8.51), respectively. All three risk scores overestimated 30-day mortality with ratios of 0.176 (95% CI 0.138-0.214), 0.342 (95% CI 0.264-0.419), and 0.536 (95% CI 0.421-0.651), respectively. 30-day mortality ROC curves demonstrated that ES II had the largest AUC at 0.722, followed by STS at 0.704, and LES at 0.698. CONCLUSIONS: All three scores overestimated mortality at 30 days with ES II showing the highest predictability compared to LES and STS; and therefore, should be recommended for ViV procedures. There is a need for a dedicated scoring system for patients undergoing ViV interventions.
- MeSH
- aortální chlopeň patofyziologie chirurgie MeSH
- bioprotézy * MeSH
- časové faktory MeSH
- chirurgická náhrada chlopně škodlivé účinky přístrojové vybavení mortalita MeSH
- hodnocení rizik MeSH
- lidé MeSH
- metody pro podporu rozhodování * MeSH
- prediktivní hodnota testů MeSH
- protézy - design MeSH
- registrace MeSH
- rizikové faktory MeSH
- selhání protézy * MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- srdeční chlopně umělé * MeSH
- transkatetrální implantace aortální chlopně škodlivé účinky přístrojové vybavení mortalita MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- pozorovací studie MeSH
- srovnávací studie MeSH
Medline Complete (EBSCOhost) od 2012-11-01 do Před 1 rokem
PubMed
27436871
DOI
10.1093/ejcts/ezw169
Knihovny.cz E-zdroje
OBJECTIVES: The objective of this study was to describe the operative experience and 30-day outcomes of patients implanted with the HeartMate 3 Left Ventricular Assist System (LVAS) during the Conformité Européenne (CE) Mark clinical trial. METHODS: Adult patients met inclusion and exclusion criteria defining advanced-stage heart failure and included the indications of bridge to transplant and destination therapy. Operative parameters, outcomes, adverse events, physical status and quality-of-life parameters were assessed in the first 30 days after LVAS implant. RESULTS: Fifty patients were implanted with the HeartMate 3 at 10 centres in 6 countries. The 30-day survival rate was 98%. The median operative and cardiopulmonary bypass times were 200 (range: 95-585) min and 84 (range: 47-250) min, respectively. Patients required transfusion with packed red blood cells (3.6 ± 2.3 units), fresh frozen plasma (6.5 ± 5 units) and platelets (2 ± 1 units). Six patients (12%) required reoperation for postoperative bleeding and 10 patients (20%) did not require blood transfusion. The median intensive care time was 6 days (range: 1-112 days) and the total hospital stay was 28 days (range: 14-116 days). The most common adverse events were bleeding (15, 30%), arrhythmia (14, 28%) and infection (10, 20%). There were 2 (4%) strokes. CONCLUSIONS: The 30-day outcomes following implantation of the HeartMate 3 demonstrates excellent survival with low adverse event rates. The LVAD performed as intended with no haemolysis or device failure. CLINICALTRIALSGOV IDENTIFIER: NCT02170363. HeartMate 3™ CE Mark Clinical Investigation Plan (HM3 CE Mark).
- MeSH
- časové faktory MeSH
- celosvětové zdraví MeSH
- délka pobytu trendy MeSH
- design vybavení MeSH
- incidence MeSH
- kvalita života MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití trendy MeSH
- následné studie MeSH
- podpůrné srdeční systémy * MeSH
- pooperační komplikace epidemiologie chirurgie MeSH
- prospektivní studie MeSH
- reoperace MeSH
- srdeční komory patofyziologie chirurgie MeSH
- srdeční selhání mortalita patofyziologie chirurgie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- multicentrická studie MeSH
Upřesnit dle MeSH
Sdílet
Název dokumentu
Po ukončení testovacího provozu bude odkaz přesměrován adresu produkční verze portálu Medvik.